
Aspirin acts as an immune modulator via platelets and T cells, an NEJM analysis suggests
Louis shares commentary on a new NEJM analysis explaining how aspirin reduces cancer metastasis. The mechanism involves platelet-derived thromboxane A2 activating an immunosuppressive pathway in T cells, which aspirin interrupts, rather than simple pain or inflammation relief.
